the safar/allergen research fellowship award allows young canadian investigators (phd or md) interested in therapies and prevention for severe food allergies to pursue academic research training at stanford university. under the leadership and vision of dr. kari nadeau, md, phd, safar brings together a broad network of team members, working across multiple disciplines, to develop new and safe therapies for food allergies.

the safar program is focused on four main areas of activity:

• providing world-class clinical food allergy care

• conducting basic research into the molecular and genetic underpinnings of the immune response that directs food allergy

• conducting clinical and social research to examine trends in the development and progression of food allergies, and the ways in which such allergies are affecting the lives of food allergic individuals (e.g. social, cultural, psychological and financial)

• training allergy fellows to become future clinical and research leaders in the field of food allergy

call for applications:

http://www.allergen-nce.ca/documents/safar_allergen%20fellowship%20guidelines_2014.pdf

application form:

http://www.allergen-nce.ca/documents/2014%20safar_allergen%20application.doc

general website:

http://www.allergen-nce.ca/

the joint call for collaborative research innovation projects in the area of “water for health” will support collaborative research projects focused on the development and evaluation of new technologies in each of the following areas:

• monitoring and management of water borne or water related diseases using mobile or networked health technologies;
• waste water treatment and impacts on water quality;
• water purification biotechnologies;
• heavy metals identification using biosensors; and,
• sustainable waste-water infrastructure and management using biotechnologies.

proposals are invited for the 2014-2015 quebec-ontario cooperation for agri-food research competition

purpose of the program

 one of the aims of the ontario–quebec trade and cooperation agreement is to improve the competitive position of the agriculture and agri-processing sectors. both provinces recognize the mutual benefits of developing common responses to the challenges facing these sectors.

the ministère de l’agriculture, des pêcheries et de l’alimentation du québec (mapaq) and the ontario ministry of agriculture and food and the ministry of rural affairs (omaf and mra) have therefore developed a joint research competition on research topics of mutual interest to both provinces.

the program objectives are as follows:

Ÿ  develop solutions to agri-food issues shared by quebec and ontario

Ÿ  encourage partnerships between quebec and ontario researchers

Ÿ  enhance graduate student training through internships in the cooperating province

it is expected that the outcomes of the joint projects will be greater than can be achieved by projects undertaken independently in each province.  therefore, proposals must clearly describe the value of the collaboration between the two provinces (e.g. may relate to identification of common sector issues, data sharing, knowledge transfer, complementary expertise, validation, expanded networks and partnerships etc.).

research priorities

proposals are solicited that will generate new knowledge and/or technologies in the following areas:

Ÿ  integrated pest management

Ÿ  water management

additional details about the research priorities can be accessed at the links provided below.

who may apply

universities and non-profit, non-governmental applied research centres are eligible to apply. each application must be submitted jointly by a research institution based in quebec and another based in ontario.

other public or private research institutions and organizations can contribute to the project as research team members or partners/co-funders. this includes colleges, government departments, industry associations and businesses.

how to apply

the competition consists of a single-stage application process, and each project requires a co-lead from an ontario and quebec institution.  applications are to be completed using the proposal form, 2014-2015 quebec-ontario cooperation for agri-food research competition. the form is available in french and english. applicants can complete and save this interactive pdf form. the application form, as well as the competition guide with complete program details, is available on the omaf and mra and mapaq websites at the following addresses:

http://www.omafra.gov.on.ca/english/research/onqc_research/index.html

http://www.omafra.gov.on.ca/french/research/onqc_research/index.html

http://www.mapaq.gouv.qc.ca/innovaction select volet 1 – recherche appliquée page.

the application deadline is tuesday, september 16, 2014 at 4 p.m.  the completed application form and their appendices, if any, must be emailed by the co-leads respective research institutions' research offices or any other equivalent authority for approval purposes as described in the competition guide. researchers must allow sufficient time for their institution’s internal approval process.

career development award – pre-application due june 10, 2014, letters of invite issued in july, full applications due september 17, 2014

principal investigator: independent investigator at the level of assistant professor, instructor, or equivalent within 7 years of first faculty appointment (or equivalent) at the time of application deadline
designated collaborator: investigators at or above the level of associate professor (or equivalent); must have a proven publication and funding record in at least one of the fy14 prcrp topic areas. may not have a major research focus on breast, prostate, lung (excluding mesothelioma), or ovarian cancer

• supports independent, early-career investigators to conduct innovative research with the mentorship of an experienced cancer researcher
• must address at least one of the fy14 prcrp topic areas
• strongly encouraged to address at least one of the fy14 prcrp military relevance focus areas
• must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
• preliminary data not required

clinical trials not allowed

• maximum funding for the entire period of performance is $360,000 in direct costs (plus indirect costs)

maximum period of performance is 3 years

idea award with special focus– pre-application due june 10, 2014, letters of invite issued in july, full applications due september 17, 2014

independent investigator at or above the level of assistant professor (or equivalent)

• supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods in cancer research that are directly relevant to service members, their families, and other military beneficiaries
• emphasis on innovation and military relevance/impact
• must address at least one of the fy14 prcrp topic areas
• must address at least one of the fy14 prcrp military relevance focus areas
• must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
• preliminary data discouraged

clinical trials not allowed

• maximum funding for the entire period of performance is $300,000 in direct costs (plus indirect costs)

maximum period of performance is 2 years

all applications must conform to the final program announcements and general application instructions available for electronic downloading from the grants.gov website. the application package containing the required forms for each award mechanism will also be found on grants.gov. a listing of all usamrmc funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

a pre-application is required and must be submitted through the cdmrp electronic biomedical research application portal (ebrap) (https://ebrap.org) prior to the pre-application deadline. applications must be submitted through the federal government's single-entry portal, grants.gov. requests for email notification of the program announcements release may be sent to help@ebrap.org. email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor grants.gov for official postings of funding opportunities.

for more information about the prcrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

various programs

• clinical trial award
• discovery award
• focused program award
• investigator-initiated research award
• technology/therapeutic development award

clinical trial award – preproposal due june 25, 2014

assistant professor level or above (or equivalent)

• supports the rapid implementation of clinical trials of novel interventions with the potential to have a significant impact on patient care in the topic area of interest
• investigational new drug or investigational device exemption applications, if needed, should be submitted to the food and drug administration before the prmrp grants.gov application submission deadline
• a clinical trial is expected to be initiated within 12 months of the award date

preproposal submission is required; application submission is by invitation only

funding limit not defined; requested funding must be appropriate for the scope of work proposed

maximum period of performance is 5 years

discovery award – letter of intent due july 16, 2014

all investigators

• supports the exploration of a highly innovative new concept or untested theory
• not intended to support the logical progression of an already established line of questioning

• clinical trials will not be funded

maximum of $200,000 for direct costs (plus indirect costs)

maximum period of performance is 18 months

focused program award - preproposal due june 25, 2014

full professor level or above (or equivalent)

new mechanism for fy14!

restricted to the topic areas of acupuncture, congenital heart disease, illnesses related to radiation exposure, metabolic disease, neuroprosthetics, psychotropic medications, respiratory health, and segmental bone defects

• supports a synergistic, multidisciplinary research program of multiple distinct but complementary projects addressing an overarching goal in one of the topic areas listed directly above
• projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications projects may range from exploratory/hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question
• research team of highly qualified, multidisciplinary project leaders should be led by a principal investigator with demonstrated success in directing large, focused projects
• individual projects submitted as part of a focused program award application may be submitted to one other fy14 prmrp program announcement/funding opportunity to increase chances of funding; however, accepting multiple grants to support the same project will not be allowed

preproposal submission is required; application submission is by invitation only

maximum of $10 million for total costs (includes direct and indirect costs)

maximum period of performance is 5 years

investigator-initiated research award - preproposal due june 20, 2014

assistant professor level or above (or equivalent)

• supports research that will make an original and important contribution to the field of research or patient care in the topic area of interest
• partnering principal investigator (pi) option available
• clinical trials will not be funded

preproposal submission is required; application submission is by invitation only

maximum of $1.2 million for direct costs (plus indirect costs)

maximum of $1.5 million for direct costs (plus indirect costs) for applications including a partnering pi option

maximum period of performance is 3 years

technology/ therapeutic development award - preproposal due june 25, 2014

assistant professor level or above (or equivalent)

• supports the development of diagnostics or therapies that have the potential to make a strong impact on patient care in the topic area of interest
• product-oriented: device, drug, clinical guidelines
• clinical trials will not be funded

preproposal submission is required; application submission is by invitation only

maximum of $1.5 million for direct costs (plus indirect costs)

maximum period of performance is 3 years

all applications must conform to the final program announcement and general application instructions that are available for electronic downloading from the grants.gov website.  the application package containing the required forms for the award mechanisms are also found on grants.gov.  a listing of all usamrmc funding opportunities can be obtained on the grants.gov website by performing a basic search using cfda number 12.420.

a pre-application is required and must be submitted through the cdmrp electronic biomedical research application portal (ebrap) (https://ebrap.org) prior to the pre-application deadline.  applications must be submitted through the federal government's single-entry portal, grants.gov.  requests for email notification of the program announcement release may be sent to help@ebrap.org.  email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor grants.gov for official postings of funding opportunities.

for more information about the prmrp or other cdmrp-administered programs, please visit the cdmrp website (http://cdmrp.army.mil).

various awards available:

• investigator-initiated research award
• innovative treatment evaluation award
• clinical trial award

the intent of the gwirp nia is to support investigators new to the field of gwi research at different stages of career development. this award enables such investigators to compete for funding separately from investigators with established programs of gwi research. previous experience in gwi research is allowed, but not required. however, principal investigators (pis) with a limited background in gwi research are strongly encouraged to strengthen their applications through collaboration with investigators who are experienced in gwi research and/or possess other relevant expertise.